Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Premature changes in trabecular and cortical microarchitecture result in decreased bone strength in hemophilia

Adrienne Lee, Steven K. Boyd, Gregory Kline, Man-Chiu Poon

Blood (2015) 125 (13): 2160–2163.

https://doi.org/10.1182/blood-2014-10-602060

Published: 2015

Journal Articles

Circulating Periostin Is Elevated In Patients With Hemoglobinopathies and Correlates With Bone Mineral Density In Double Heterozygous Sickle-Cell/Beta-Thalassemia Patients; A Novel Marker Of Bone Strength?

Ersi Voskaridou, Dimitrios Christoulas, Athanasios Papatheodorou, Panagiotis Oikonomopoulos, Veroniki Komninaka, Konstantina Repa, Evangelos Terpos

Blood (2013) 122 (21): 3445.

https://doi.org/10.1182/blood.V122.21.3445.3445

Published: 2013

Journal Articles

Circulating Activin-A Is Elevated in Patients with Thalassemia Major and Double Heterozygous Sickle-Cell/Beta-Thalassemia and Correlates with Markers of Hemolysis and Bone Mineral Density

Ersi Voskaridou, Dimitrios Christoulas, Maria Dimopoulou, Veroniki Komninaka, Maria Tsalkani, Athanasios Papatheodorou, Evangelos Terpos

Blood (2012) 120 (21): 3256.

https://doi.org/10.1182/blood.V120.21.3256.3256

Published: 2012

Journal Articles

High Circulating Levels of Sclerostin Correlate with Bone Mineral Density In Patients with Thalassemia and Osteoporosis: The Role of the Wnt Signaling In the Pathogenesis of Bone Loss In Thalassemia

Ersi Voskaridou, Dimitrios Christoulas, Athanasios Papatheodorou, Cornelia Bratengeier, Eleni Plata, Despoina Kaliontzi, Wolfgang Woloszczuk, Evangelos Terpos

Blood (2010) 116 (21): 1010.

https://doi.org/10.1182/blood.V116.21.1010.1010

Published: 2010

Journal Articles

Analysis of Bone Mineral Density, Biochemical Bone Turnover Markers and Serum Tryptase Levels in Patients with Systemic Mastocytosis (SM).

Akif S. Yavuz, Nilüfer Alpay, Öner Dogan, Nesimi Büyükbabani, Can Baykal, Dilsad Sindel, Yüksel Pekçelen, Refik Tanakol

Blood (2007) 110 (11): 4662.

https://doi.org/10.1182/blood.V110.11.4662.4662

Published: 2007

Journal Articles

Bone Microarchitecture Parameter for Early Diagnosis of Osteopenia in Thalassemia.

Regine Grosse, MD, Isolde Frieling, MD, Ellen B. Fung, PhD, Achim Wuesthof, MD, Hans P. Kruse, MD, Roland Fischer, PhD, Gritta E. Janka, MD

Blood (2007) 110 (11): 2772.

https://doi.org/10.1182/blood.V110.11.2772.2772

Published: 2007

Journal Articles

Clinical Evaluation of Bone Mineral Density (BMD) and Bone Metabolism in Hereditary Hemochromatosis (HH).

Yu Ying Yau, Charles D. Bolan, Stacey A. Cecco, Nadja N. Rehak, Michael Collins, James Reynolds, Susan F. Leitman

Blood (2005) 106 (11): 3727.

https://doi.org/10.1182/blood.V106.11.3727.3727

Published: 2005

NARROW

Premature changes in trabecular and cortical microarchitecture result in decreased bone strength in hemophilia

Circulating Periostin Is Elevated In Patients With Hemoglobinopathies and Correlates With Bone Mineral Density In Double Heterozygous Sickle-Cell/Beta-Thalassemia Patients; A Novel Marker Of Bone Strength?

Circulating Activin-A Is Elevated in Patients with Thalassemia Major and Double Heterozygous Sickle-Cell/Beta-Thalassemia and Correlates with Markers of Hemolysis and Bone Mineral Density

High Circulating Levels of Sclerostin Correlate with Bone Mineral Density In Patients with Thalassemia and Osteoporosis: The Role of the Wnt Signaling In the Pathogenesis of Bone Loss In Thalassemia

Analysis of Bone Mineral Density, Biochemical Bone Turnover Markers and Serum Tryptase Levels in Patients with Systemic Mastocytosis (SM).

Bone Microarchitecture Parameter for Early Diagnosis of Osteopenia in Thalassemia.

Clinical Evaluation of Bone Mineral Density (BMD) and Bone Metabolism in Hereditary Hemochromatosis (HH).

Email alerts

ASH Publications

American Society of Hematology

Premature changes in trabecular and cortical microarchitecture result in decreased bone strength in hemophilia

Circulating Periostin Is Elevated In Patients With Hemoglobinopathies and Correlates With Bone Mineral Density In Double Heterozygous Sickle-Cell/Beta-Thalassemia Patients; A Novel Marker Of Bone Strength?

Circulating Activin-A Is Elevated in Patients with Thalassemia Major and Double Heterozygous Sickle-Cell/Beta-Thalassemia and Correlates with Markers of Hemolysis and Bone Mineral Density

High Circulating Levels of Sclerostin Correlate with Bone Mineral Density In Patients with Thalassemia and Osteoporosis: The Role of the Wnt Signaling In the Pathogenesis of Bone Loss In Thalassemia

Analysis of Bone Mineral Density, Biochemical Bone Turnover Markers and Serum Tryptase Levels in Patients with Systemic Mastocytosis (SM).

Bone Microarchitecture Parameter for Early Diagnosis of Osteopenia in Thalassemia.

Clinical Evaluation of Bone Mineral Density (BMD) and Bone Metabolism in Hereditary Hemochromatosis (HH).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only